Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMedDx’s New Chairman Is BD Exec Vince Forlenza

This article was originally published in The Gray Sheet

Executive Summary

Becton Dickinson President Vince Forlenza is the new chairman of AdvaMedDx, the division of the Advanced Medical Technology Association focused on in vitro diagnostics, the group announced Oct. 20 at the AdvaMed 2010 conference in Washington, D.C.

You may also be interested in...



AdvaMedDx Steps Into Public Sphere: Director Details Diagnostics Priorities

The recently established diagnostics arm of AdvaMed had what its executive director called a coming out party last week.

AdvaMedDx Steps Into Public Sphere: Director Details Diagnostics Priorities

The recently established diagnostics arm of AdvaMed had what its executive director called a coming out party last week.

Beckman CEO Resigns As Company Faces Regulatory Challenges

Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel